| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.11 | 0.6 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.6 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.075 | 0.6 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.034 | 0.6 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.1 | 0.6 |